Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling

Yu D, Zhao W, Vallega KA, Sun SY

Lung Cancer: Targets and Therapy 2021, 12:1-10

Published Date: 5 February 2021